These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19025098)

  • 21. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K
    Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy and prophylaxis of systemic protozoan infections.
    Van Voorhis WC
    Drugs; 1990 Aug; 40(2):176-202. PubMed ID: 2121456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of trypanosomiasis and leishmaniasis.
    Barrett MP; Croft SL
    Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New pentamidine analogues in medicinal chemistry.
    Porcheddu A; Giacomelli G; De Luca L
    Curr Med Chem; 2012; 19(34):5819-36. PubMed ID: 23092128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
    Cardona-G W; Yepes AF; Herrera-R A
    Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiprotozoal agents: How have they changed over a decade?
    Fernandes VS; da Rosa R; Zimmermann LA; Rogério KR; Kümmerle AE; Bernardes LSC; Graebin CS
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100338. PubMed ID: 34661935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activity of Nifurmazole (CB 10,615) on Trypanosoma equiperdum, Schizotrypanum cruzi and Trypanosoma gambiense].
    Vindel J; Catalan F; Navarro J; Siou G
    C R Acad Hebd Seances Acad Sci D; 1970 May; 270(20):2512-5. PubMed ID: 4987585
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
    Mantoani SP; de Andrade P; Chierrito TPC; Figueredo AS; Carvalho I
    Curr Med Chem; 2019; 26(23):4403-4434. PubMed ID: 28748757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.
    Herrera Acevedo C; Scotti L; Feitosa Alves M; Formiga Melo Diniz MF; Scotti MT
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of pentamidine in protozoan diseases].
    Kern P
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():231-5. PubMed ID: 2197531
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
    Don R; Ioset JR
    Parasitology; 2014 Jan; 141(1):140-6. PubMed ID: 23985066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Amazing World of Peptide Engineering: the Example of Antimicrobial Peptides from Frogs and Their Analogues.
    Guimarães AB; Costa FJ; Pires OR; Fontes W; Castro MS
    Protein Pept Lett; 2016; 23(8):722-37. PubMed ID: 27262306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes.
    Gilbert IH
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):249-57. PubMed ID: 12084467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J
    Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches for development of new antiprotozoan drugs.
    Soares MB
    Curr Drug Targets; 2009 Mar; 10(3):176-7. PubMed ID: 19275554
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological approaches to antitrypanosomal chemotherapy.
    Croft SL
    Mem Inst Oswaldo Cruz; 1999; 94(2):215-20. PubMed ID: 10224531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.